• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Friday, August 29, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News

Null results research now published by major behavioral medicine journal

Bioengineer by Bioengineer
January 3, 2017
in Science News
Reading Time: 3 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram
IMAGE

Credit: Society of Behavioral Medicine

Translational Behavioral Medicine, a major scientific behavioral medicine journal, now publishes research studies that have null results.

Some in the scientific community view null results research as a failure because, by its very definition, a null result means what you expected would happen in your study did not happen. But Translational Behavioral Medicine (TBM) Editor-in-Chief Suzanne Miller-Halegoua, PhD, disagrees with that assessment.

"Some of our best scientific findings were not expected and could have been called failures. Penicillin of course comes to mind when you're thinking of unplanned health advancements," Dr. Miller said. "Throwing your research away because you didn't find what you thought you'd find wastes valuable time and dollars, and it limits the potential of the overall field of medicine. There is so much that we as a scientific community can learn from what doesn't go as planned."

TBM's first null results study, published Oct. 31, provides a perfect example. Researchers sent pregnant women text messages that encouraged them to be physically active. The researchers varied the frequency and timing of the messages, to see which combination helped the women the most. They expected one of the combinations to clearly stand out. But, to their surprise, none of the patterns increased the women's physical activity.

Because this study was published rather than discarded, future researchers now know text messages alone are not enough to increase physical activity in pregnant women. Rather than testing text messages again, they can move on to testing other ideas, like the use of pedometers or goal-setting strategies.

TBM's publication of null results research sets it apart from other behavioral medicine titles, according to its publisher, Springer Nature.

"TBM is providing a unique and important opportunity to scientific researchers," said Springer Health and Behavior Senior Editor Janice Stern. "The journal stands out within the behavioral health and policy field in supporting the publication of null results research."

TBM's new emphasis on null results is proudly supported by the journal's owner, the Milwaukee-based Society of Behavioral Medicine (SBM). The society recently began including null results research in scientific presentations at its annual conference.

"Sharing null results research is critical to advancing science and making the best use of our scarce research resources and dollars," said SBM conference planning committee Chair David X. Marquez, PhD. "We've been encouraging our society members to use null results research as learning opportunities and TBM's publication of null studies will go a long way in achieving that goal."

TBM will consider papers with null findings if they have a strong research design and use advanced methods with appropriate statistical analysis. A necessary condition for publication is that the study is powered to accept the null hypothesis. Authors should include a detailed description of the hypothesis, intervention, recruitment strategy, and power calculation. They should also address the lessons learned as a result of the null findings, discuss how the null findings advance the field, and describe plans for future studies. Researchers can submit their null results work online.

Translational Behavioral Medicine (TBM) is an international peer-reviewed journal that offers continuous, online-first publication. TBM's mission is to engage, inform, and catalyze dialogue between the research, practice, and policy communities about behavioral medicine. The journal's 2015 impact factor is 2.189. The journal is owned by the Society of Behavioral Medicine and published by Springer Nature. Read the journal online (http://www.springer.com/medicine/journal/13142).

The Society of Behavioral Medicine (SBM) is a 2,300-member organization of scientific researchers, clinicians and educators. They study interactions among behavior, biology and the environment, and translate findings into interventions that improve the health and well-being of individuals, families and communities (http://www.sbm.org).

###

Media Contact

Lindsay Bullock
[email protected]
414-918-3156
@SpringerNature

http://www.springer.com

############

Story Source: Materials provided by Scienmag

Share22Tweet14Share4ShareShareShare3

Related Posts

Mitophagy and Proteasomal Degradation Defend Postnatal Muscle Health

August 29, 2025

Transplant Policies: Undocumented Immigrants vs. Tourists

August 29, 2025

Revolutionizing Primary Care with Generative AI Solutions

August 29, 2025

Enhanced Outcomes with Revised Oocyte Warming Protocol

August 29, 2025
Please login to join discussion

POPULAR NEWS

  • blank

    Breakthrough in Computer Hardware Advances Solves Complex Optimization Challenges

    150 shares
    Share 60 Tweet 38
  • Molecules in Focus: Capturing the Timeless Dance of Particles

    142 shares
    Share 57 Tweet 36
  • New Drug Formulation Transforms Intravenous Treatments into Rapid Injections

    116 shares
    Share 46 Tweet 29
  • Neuropsychiatric Risks Linked to COVID-19 Revealed

    82 shares
    Share 33 Tweet 21

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Mitophagy and Proteasomal Degradation Defend Postnatal Muscle Health

Transplant Policies: Undocumented Immigrants vs. Tourists

Revolutionizing Primary Care with Generative AI Solutions

  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.